| 摘要 |
<p>The present invention relates to compositions comprising voriconazole and less than, or equal to, about 0.17 w/w% of 2,4-difluro-1 H -1-yl-1,2,4-triazolacetophenone, in particular aqueous solutions and lyophilized powders, and improved formulation processes therefor</p> |
